Organization of the apical extracellular matrix during tubular organ formation
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (Review Commons)
Abstract
The apical extracellular matrix (aECM) plays a critical role in epithelial tube morphogenesis during organ formation, but its composition and organization remain poorly understood. Using the Drosophila embryonic salivary gland (SG) as a model, we identify Papss, an enzyme that synthesizes the universal sulfate donor PAPS, as a critical regulator of tube lumen expansion. Papss mutants show a disorganized apical membrane, condensed aECM, and disruptions in Golgi structures and intracellular trafficking. Additionally, we identify two zona pellucida (ZP) domain proteins, Piopio (Pio) and Dumpy (Dpy), as key components of the SG aECM. In the absence of Papss , Pio is gradually lost in the aECM, while the Dpy-positive aECM structure is condensed and dissociates from the apical membrane, leading to a thin lumen. Mutations in dpy or pio , or in Notopleural , which encodes a matriptase that cleaves Pio to form the luminal Pio pool, result in a SG lumen with alternating bulges and constrictions, with the loss of pio leading to the loss of Dpy in the lumen. Our findings underscore the essential role of sulfation in organizing the aECM during tubular organ formation and highlight the mechanical support provided by ZP domain proteins in maintaining luminal diameter.
Article activity feed
-
Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.
Learn more at Review Commons
Reply to the reviewers
Reviewer #1 (Evidence, reproducibility and clarity (Required)):
PAPS is required for all sulfotransferase reactions in which a sulfate group is covalently attached to amino acid residues of proteins or to side chains of proteoglycans. This sulfation is crucial for properly organizing the apical extracellular matrix (aECM) and expanding the lumen in the Drosophila salivary gland. Loss of Papss potentially leads to decreased sulfation, disorganizing the aECM, and defects in lumen formation. In addition, Papss loss destabilizes the Golgi structures.
In Papss mutants, several changes occur in the salivary gland lumen of Drosophila. The tube lumen is very …
Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.
Learn more at Review Commons
Reply to the reviewers
Reviewer #1 (Evidence, reproducibility and clarity (Required)):
PAPS is required for all sulfotransferase reactions in which a sulfate group is covalently attached to amino acid residues of proteins or to side chains of proteoglycans. This sulfation is crucial for properly organizing the apical extracellular matrix (aECM) and expanding the lumen in the Drosophila salivary gland. Loss of Papss potentially leads to decreased sulfation, disorganizing the aECM, and defects in lumen formation. In addition, Papss loss destabilizes the Golgi structures.
In Papss mutants, several changes occur in the salivary gland lumen of Drosophila. The tube lumen is very thin and shows irregular apical protrusions. There is a disorganization of the apical membrane and a compaction of the apical extracellular matrix (aECM). The Golgi structures and intracellular transport are disturbed. In addition, the ZP domain proteins Piopio (Pio) and Dumpy (Dpy) lose their normal distribution in the lumen, which leads to condensation and dissociation of the Dpy-positive aECM structure from the apical membrane. This results in a thin and irregularly dilated lumen.
- The authors describe various changes in the lumen in mutants, from thin lumen to irregular expansion. I would like to know the correct lumen diameter, and length, besides the total area, by which one can recognize thin and irregular.
We have included quantification of the length and diameter of the salivary gland lumen in the stage 16 salivary glands of control, Papss mutant, and salivary gland-specific rescue embryos (Figure 1J, K). As described, Papss mutant embryos have two distinct phenotypes, one group with a thin lumen along the entire lumen and the other group with irregular lumen shapes. Therefore, we separated the two groups for quantification of lumen diameter. Additionally, we have analyzed the degree of variability for the lumen diameter to better capture the range of phenotypes observed (Figure 1K'). These quantifications enable a more precise assessment of lumen morphology, allowing readers to distinguish between thin and irregular lumen phenotypes.
The rescue is about 30%, which is not as good as expected. Maybe the wrong isoform was taken. Is it possible to find out which isoform is expressed in the salivary glands, e.g., by RNA in situ Hyb? This could then be used to analyze a more focused rescue beyond the paper.
Thank you for this point, but we do not agree that the rescue is about 30%. In Papss mutants, about 50% of the embryos show the thin lumen phenotype whereas the other 50% show irregular lumen shapes. In the rescue embryos with a WT Papss, few embryos showed thin lumen phenotypes. About 40% of the rescue embryos showed "normal, fully expanded" lumen shapes, and the remaining 60% showed either irregular (thin+expanded) or slightly overexpanded lumen. It is not uncommon that rescue with the Gal4/UAS system results in a partial rescue because it is often not easy to achieve the balance of the proper amount of the protein with the overexpression system.
To address the possibility that the wrong isoform was used, we performed in situ hybridization to examine the expression of different Papss spice forms in the salivary gland. We used probes that detect subsets of splice forms: A/B/C/F/G, D/H, and E/F/H, and found that all probes showed expression in the salivary gland, with varying intensities. The original probe, which detects all splice forms, showed the strongest signals in the salivary gland compared to the new probes which detect only a subset. However, the difference in the signal intensity may be due to the longer length of the original probe (>800 bp) compared to other probes that were made with much smaller regions (~200 bp). Digoxigenin in the DIG labeling kit for mRNA detection labels the uridine nucleotide in the transcript, and the probes with weaker signals contain fewer uridines (all: 147; ABCFG, 29; D, 36; EFH, 66). We also used the Papss-PD isoform, for a salivary gland-specific rescue experiment and obtained similar results to those with Papss-PE (Figure 1I-L, Figure 4D and E).
Furthermore, we performed additional experiments to validate our findings. We performed a rescue experiment with a mutant form of Papss that has mutations in the critical rescues of the catalytic domains of the enzyme, which failed to rescue any phenotypes, including the thin lumen phenotype (Figure 1H, J-L), the number and intensity of WGA puncta (Figure 3I, I'), and cell death (Figure 4D, E). These results provide strong evidence that the defects observed in Papss mutants are due to the lack of sulfation.
Crb is a transmembrane protein on the apicolateral side of the membrane. Accordingly, the apicolateral distribution can be seen in the control and the mutant. I believe there are no apparent differences here, not even in the amount of expression. However, the view of the cells (frame) shows possible differences. To be sure, a more in-depth analysis of the images is required. Confocal Z-stack images, with 3D visualization and orthogonal projections to analyze the membranes showing Crb staining together with a suitable membrane marker (e.g. SAS or Uif). This is the only way to show whether Crb is incorrectly distributed. Statistics of several papas mutants would also be desirable and not just a single representative image. When do the observed changes in Crb distribution occur in the development of the tubes, only during stage 16? Is papss only involved in the maintenance of the apical membrane? This is particularly important when considering the SJ and AJ, because the latter show no change in the mutants.
We appreciate your suggestion to more thoroughly analyze Crb distribution. We adapted a method from a previous study (Olivares-Castiñeira and Llimargas, 2017) to quantify Crb signals in the subapical region and apical free region of salivary gland cells. Using E-Cad signals as a reference, we marked the apical cell boundaries of individual cells and calculated the intensity of Crb signals in the subapical region (along the cell membrane) and in the apical free region. We focused on the expanded region of the SG lumen in Papss mutants for quantification, as the thin lumen region was challenging to analyze. This quantification is included in Figure 2D. Statistical analysis shows that Crb signals were more dispersed in SG cells in Papss mutants compared to WT.
A change in the ECM is only inferred based on the WGA localization. This is too few to make a clear statement. WGA is only an indirect marker of the cell surface and glycosylated proteins, but it does not indicate whether the ECM is altered in its composition and expression. Other important factors are missing here. In addition, only a single observation is shown, and statistics are missing.
We understand your concern that WGA localization alone may not be sufficient to conclude changes in the ECM. However, we observed that luminal WGA signals colocalize with Dpy-YFP in the WT SG (Figure 5-figure supplement 2C), suggesting that WGA detects the aECM structure containing Dpy. The similar behavior of WGA and Dpy-YFP signals in multiple genotypes further supports this idea. In Papss mutants with a thin lumen phenotype, both WGA and Dpy-YFP signals are condensed (Figure 5E-H), and in pio mutants, both are absent from the lumen (Figure 6B, D). We analyzed WGA signals in over 25 samples of WT and Papss mutants, observing consistent phenotypes. We have included the number of samples in the text. While we acknowledge that WGA is an indirect marker, our data suggest that it is a reliable indicator of the aECM structure containing Dpy.
Reduced WGA staining is seen in papss mutants, but this could be due to other circumstances. To be sure, a statistic with the number of dots must be shown, as well as an intensity blot on several independent samples. The images are from single confocal sections. It could be that the dots appear in a different Z-plane. Therefore, a 3D visualization of the voxels must be shown to identify and, at best, quantify the dots in the organ.
We have quantified cytoplasmic punctate WGA signals. Using spinning disk microscopy with super-resolution technology (Olympus SpinSR10 Sora), we obtained high-resolution images of cytoplasmic punctate signals of WGA in WT, Papss mutant, and rescue SGs with the WT and mutant forms of Papss-PD. We then generated 3D reconstructed images of these signals using Imaris software (Figure 3E-H) and quantified the number and intensity of puncta. Statistical analysis of these data confirms the reduction of the number and intensity of WGA puncta in Papss mutants (Figure 3I, I'). The number of WGA puncta was restored by expressing WT Papss but not the mutant form. By using 3D visualization and quantification, we have ensured that our results are not limited to a single confocal section and account for potential variations in Z-plane localization of the dots.
A colocalization analysis (statistics) should be shown for the overlap of WGA with ManII-GFP.
Since WGA labels multiple structures, including the nuclear envelope and ECM structures, we focused on assessing the colocalization of the cytoplasmic WGA punctate signals and ManII-GFP signals. Standard colocalization analysis methods, such as Pearson's correlation coefficient or Mander's overlap coefficient, would be confounded by WGA signals in other tissues. Therefore, we used a fluorescent intensity line profile to examine the spatial relationship between WGA and ManII-GFP signals in WT and Papss mutants (Figure 3L, L').
I do not understand how the authors describe "statistics of secretory vesicles" as an axis in Figure 3p. The TEM images do not show labeled secretory vesicles but empty structures that could be vesicles.
Previous studies have analyzed "filled" electron-dense secretory vesicles in TEM images of SG cells (Myat and Andrew, 2002, Cell; Fox et al., 2010, J Cell Biol; Chung and Andrew, 2014, Development). Consistent with these studies, our WT TEM images show these vesicles. In contrast, Papss mutants show a mix of filled and empty structures. For quantification, we specifically counted the filled electron-dense vesicles (now Figure 3W). A clear description of our analysis is provided in the figure legend.
- The quality of the presented TEM images is too low to judge any difference between control and mutants. Therefore, the supplement must present them in better detail (higher pixel number?).
We disagree that the quality of the presented TEM images is too low. Our TEM images have sufficient resolution to reveal details of many subcellular structures, such as mitochondrial cisternae. The pdf file of the original submission may not have been high resolution. To address this concern, we have provided several original high-quality TEM images of both WT and Papss mutants at various magnifications in Figure 2-figure supplement 2. Additionally, we have included low-magnification TEM images of WT and Papss mutants in Figure 2H and I to provide a clearer view of the overall SG lumen morphology.
Line 266: the conclusion that apical trafficking is "significantly impaired" does not hold. This implies that Papss is essential for apical trafficking, but the analyzed ECM proteins (Pio, Dumpy) are found apically enriched in the mutants, and Dumpy is even secreted. Moreover, they analyze only one marker, Sec15, and don't provide data about the quantification of the secretion of proteins.
We agree and have revised our statement to "defective sulfation affects Golgi structures and multiple routes of intracellular trafficking".
DCP-1 was used to detect apoptosis in the glands to analyze acellular regions. However, the authors compare ST16 control with ST15 mutant salivary glands, which is problematic. Further, it is not commented on how many embryos were analyzed and how often they detect the dying cells in control and mutant embryos. This part must be improved.
Thank you for the comment. We agree and have included quantification. We used stage 16 samples from WT and Papss mutants to quantify acellular regions. Since DCP-1 signals are only present at a specific stage of apoptosis, some acellular regions do not show DCP-1 signals. Therefore, we counted acellular regions regardless of DCP-1 signals. We also quantified this in rescue embryos with WT and mutant forms of Papss, which show complete rescue with WT and no rescue with the mutant form, respectively. The graph with a statistical analysis is included (Figure 4D, E).
WGA and Dumpy show similar condensed patterns within the tube lumen. The authors show that dumpy is enriched from stage 14 onwards. How is it with WGA? Does it show the same pattern from stage 14 to 16? Papss mutants can suffer from a developmental delay in organizing the ECM or lack of internalization of luminal proteins during/after tube expansion, which is the case in the trachea.
Dpy-YFP and WGA show overlapping signals in the SG lumen throughout morphogenesis. Dpy-YFP is SG enriched in the lumen from stage 11, not stage 14 (Figure 5-figure supplement 2). WGA is also detected in the lumen throughout SG morphogenesis, similar to Dpy. In the original supplemental figure, only a stage 16 SG image was shown for co-localization of Dpy-YFP and WGA signals in the SG lumen. We have now included images from stage 14 and 15 in Figure 5-figure supplement 2C.
Given that luminal Pio signals are lost at stage 16 only and that Dpy signals appear as condensed structures in the lumen of Papss mutants, it suggests that the internalization of luminal proteins is not impaired in Papss mutants. Rather, these proteins are secreted but fail to organize properly.
Line 366. Luminal morphology is characterized by bulging and constrictions. In the trachea, bulges indicate the deformation of the apical membrane and the detachment from the aECM. I can see constrictions and the collapsed tube lumen in Fig. 6C, but I don't find the bulges of the apical membrane in pio and Np mutants. Maybe showing it more clearly and with better quality will be helpful.
Since the bulging phenotype appears to vary from sample to sample, we have revised the description of the phenotype to "constrictions" to more accurately reflect the consistent observations. We quantified the number of constrictions along the entire lumen in pio and Np mutants and included the graph in Figure 6F.
The authors state that Papss controls luminal secretion of Pio and Dumpy, as they observe reduced luminal staining of both in papss mutants. However, the mCh-Pio and Dumpy-YFP are secreted towards the lumen. Does papss overexpression change Pio and Dumpy secretion towards the lumen, and could this be another explanation for the multiple phenotypes?
Thank you for the comment. To clarify, we did not observe reduced luminal staining of Pio and Dpy in Papss mutants, nor did we state that Papss controls luminal secretion of Pio and Dpy. In Papss mutants, Pio luminal signals are absent specifically at stage 16 (Figure 5H), whereas strong luminal Pio signals are present until stage 15 (Figure 5G). For Dpy-YFP, the signals are not reduced but condensed in Papss mutants from stages 14-16 (Figure 5D, H).
It remains unclear whether the apparent loss of Pio signals is due to a loss of Pio protein in the lumen or due to epitope masking resulting from protein aggregation or condensation. As noted in our response to Comment 11 internalization of luminal proteins seems unaffected in Papss mutants; proteins like Pio and Dpy are secreted into the lumen but fail to properly organize. Therefore, we have not tested whether Papss overexpression alters the secretion of Pio or Dpy.
In our original submission, we incorrectly stated that uniform luminal mCh-Pio signals were unchanged in Papss mutants. Upon closer examination, we found these signals are absent in the expanded luminal region in stage 16 SG (where Dpy-YFP is also absent), and weak mCh-Pio signals colocalize with the condensed Dpy-YFP signals (Figure 5C, D). We have revised the text accordingly.
Regulation of luminal ZP protein level is essential to modulate the tube expansion; therefore, Np releases Pio and Dumpy in a controlled manner during st15/16. Thus, the analysis of Pio and Dumpy in NP overexpression embryos will be critical to this manuscript to understand more about the control of luminal ZP matrix proteins.
Thanks for the insightful suggestion. We overexpressed both the WT and mutant form of Np using UAS-Np.WT and UAS-Np.S990A lines (Drees et al., 2019) and analyzed mCh-Pio, Pio antibody, and Dpy-YFP signals. It is important to note that these overexpression experiments were done in the presence of the endogenous WT Np.
Overexpression of Np.WT led to increased levels of mCh-Pio, Pio, and Dpy-YFP signals in the lumen and at the apical membrane. In contrast, overexpression of Np.S990A resulted in a near complete loss of luminal mCh-Pio signals. Pio antibody signals remained strong at the apical membrane but was weaker in the luminal filamentous structures compared to WT.
Due to the GFP tag present in the UAS-Np.S990A line, we could not reliably analyze Dpy-YFP signals because of overlapping fluorescent signals in the same channel. However, the filamentous Pio signals in the lumen co-localized with GFP signals, suggesting that these structures might also include Dpy-YFP, although this cannot be confirmed definitively.
These results suggest that overexpressed Np.S990A may act in a dominant-negative manner, competing with endogenous Np and impairing proper cleavage of Pio (and mCh-Pio). Nevertheless, some level of cleavage by endogenous Np still appears to occur, as indicated by the residual luminal filamentous Pio signals. These new findings have been incorporated into the revised manuscript and are shown in Figure 6H and 6I.
Minor: Fig. 5 C': mChe-Pio and Dumpy-YFP are mixed up at the top of the images.
Thanks for catching this error. It has been corrected.
Sup. Fig7. A shows Pio in purple but B in green. Please indicate it correctly.
It has been corrected.
Reviewer #1 (Significance (Required)):
In 2023, the functions of Pio, Dumpy, and Np in the tracheal tubes of Drosophila were published. The study here shows similar results, with the difference that the salivary glands do not possess chitin, but the two ZP proteins Pio and Dumpy take over its function. It is, therefore, a significant and exciting extension of the known function of the three proteins to another tube system. In addition, the authors identify papss as a new protein and show its essential function in forming the luminal matrix in the salivary glands. Considering the high degree of conservation of these proteins in other species, the results presented are crucial for future analyses and will have further implications for tubular development, including humans.
Reviewer #2 (Evidence, reproducibility and clarity (Required)):
Summary: There is growing appreciation for the important of luminal (apical) ECM in tube development, but such matrices are much less well understood than basal ECMs. Here the authors provide insights into the aECM that shapes the Drosophila salivary gland (SG) tube and the importance of PAPSS-dependent sulfation in its organization and function.
The first part of the paper focuses on careful phenotypic characterization of papss mutants, using multiple markers and TEM. This revealed reduced markers of sulfation (Alcian Blue staining) and defects in both apical and basal ECM organization, Golgi (but not ER) morphology, number and localization of other endosomal compartments, plus increased cell death. The authors focus on the fact that papss mutants have an irregular SG lumen diameter, with both narrowed regions and bulged regions. They address the pleiotropy, showing that preventing the cell death and resultant gaps in the tube did not rescue the SG luminal shape defects and discussing similarities and differences between the papss mutant phenotype and those caused by more general trafficking defects. The analysis uses a papss nonsense mutant from an EMS screen - I appreciate the rigorous approach the authors took to analyze transheterozygotes (as well as homozygotes) plus rescued animals in order to rule out effects of linked mutations.
The 2nd part of the paper focuses on the SG aECM, showing that Dpy and Pio ZP protein fusions localize abnormally in papss mutants and that these ZP mutants (and Np protease mutants) have similar SG lumen shaping defects to the papss mutants. A key conclusion is that SG lumen defects correlate with loss of a Pio+Dpy-dependent filamentous structure in the lumen. These data suggest that ZP protein misregulation could explain this part of the papss phenotype.
Overall, the text is very well written and clear. Figures are clearly labeled. The methods involve rigorous genetic approaches, microscopy, and quantifications/statistics and are documented appropriately. The findings are convincing, with just a few things about the fusions needing clarification.
minor comments
- Although the Dpy and Qsm fusions are published reagents, it would still be helpful to mention whether the tags are C-terminal as suggested by the nomenclature, and whether Westerns have been performed, since (as discussed for Pio) cleavage could also affect the appearance of these fusions.
Thanks for the comment. Dpy-YFP is a knock-in line in which YFP is inserted into the middle of the dpy locus (Lye et al., 2014; the insertion site is available on Flybase). mCh-Qsm is also a knock-in line, with mCh inserted near the N-terminus of the qsm gene using phi-mediated recombination using the qsmMI07716 line (Chu and Hayashi, 2021; insertion site available on Flybase). Based on this, we have updated the nomenclature from Qsm-mCh to mCh-Qsm throughout the manuscript to accurately reflect the tag position. To our knowledge, no western blot has been performed on Dpy-YFP or mCh-Qsm lines. We have mentioned this explicitly in the Discussion.
The Dpy-YFP reagent is a non-functional fusion and therefore may not be a wholly reliable reporter of Dpy localization. There is no antibody confirmation. As other reagents are not available to my knowledge, this issue can be addressed with text acknowledgement of possible caveats.
Thanks for raising this important point. We have added a caveat in the Discussion noting this limitation and the need for additional tools, such as an antibody or a functional fusion protein, to confirm the localization of Dpy.
TEM was done by standard chemical fixation, which is fine for viewing intracellular organelles, but high pressure freezing probably would do a better job of preserving aECM structure, which looks fairly bad in Fig. 2G WT, without evidence of the filamentous structures seen by light microscopy. Nevertheless, the images are sufficient for showing the extreme disorganization of aECM in papss mutants.
We agree that HPF is a better method and intent to use the HPF system in future studies. We acknowledge that chemical fixation contributes to the appearance of a gap between the apical membrane and the aECM, which we did not observe in the HPF/FS method (Chung and Andrew, 2014). Despite this, the TEM images still clearly reveal that Papss mutants show a much thinner and more electron-dense aECM compared to WT (Figure 2H, I), consistent to the condensed WGA, Dpy, and Pio signals in our confocal analyses. As the reviewer mentioned, we believe that the current TEM data are sufficient to support the conclusion of severe aECM disorganization and Golgi defects in Papss mutants.
The authors may consider citing some of the work that has been done on sulfation in nematodes, e.g. as reviewed here: https://pubmed.ncbi.nlm.nih.gov/35223994/ Sulfation has been tied to multiple aspects of nematode aECM organization, though not specifically to ZP proteins.
Thank you for the suggestion. Pioneering studies in C. elegans have highlighted the key role of sulfation in diverse developmental processes, including neuronal organization, reproductive tissue development, and phenotypic plasticity. We have now cited several works.
Reviewer #2 (Significance (Required)):
This study will be of interest to researchers studying developmental morphogenesis in general and specifically tube biology or the aECM. It should be particularly of interest to those studying sulfation or ZP proteins (which are broadly present in aECMs across organisms, including humans).
This study adds to the literature demonstrating the importance of luminal matrix in shaping tubular organs and greatly advances understanding of the luminal matrix in the Drosophila salivary gland, an important model of tubular organ development and one that has key matrix differences (such as no chitin) compared to other highly studied Drosophila tubes like the trachea.
The detailed description of the defects resulting from papss loss suggests that there are multiple different sulfated targets, with a subset specifically relevant to aECM biology. A limitation is that specific sulfated substrates are not identified here (e.g. are these the ZP proteins themselves or other matrix glycoproteins or lipids?); therefore it's not clear how direct or indirect the effects of papss are on ZP proteins. However, this is clearly a direction for future work and does not detract from the excellent beginning made here.
My expertise: I am a developmental geneticist with interests in apical ECM
Reviewer #3 (Evidence, reproducibility and clarity (Required)):
In this work Woodward et al focus on the apical extracellular matrix (aECM) in the tubular salivary gland (SG) of Drosophila. They provide new insights into the composition of this aECM, formed by ZP proteins, in particular Pio and Dumpy. They also describe the functional requirements of PAPSS, a critical enzyme involved in sulfation, in regulating the expansion of the lumen of the SG. A detailed cellular analysis of Papss mutants indicate defects in the apical membrane, the aECM and in Golgi organization. They also find that Papss control the proper organization of the Pio-Dpy matrix in the lumen. The work is well presented and the results are consistent.
Main comments
- This work provides a detailed description of the defects produced by the absence of Papss. In addition, it provides many interesting observations at the cellular and tissular level. However, this work lacks a clear connection between these observations and the role of sulfation. Thus, the mechanisms underlying the phenotypes observed are elusive. Efforts directed to strengthen this connection (ideally experimentally) would greatly increase the interest and relevance of this work.
Thank you for this thoughtful comment. To directly test whether the phenotypes observed in Papss mutants are due to the loss of sulfation activity, we generated transgenic lines expressing catalytically inactive forms of Papss, UAS-PapssK193A, F593P, in which key residues in the APS kinase and ATP sulfurylase domains are mutated. Unlike WT UAS-Papss (both the Papss-PD or Papss-PE isoforms), the catalytically inactive UAS-Papssmut failed to rescue any of the phenotypes, including the thin lumen phenotype (Figure 1I-L), altered WGA signals (Figure I, I') and the cell death phenotype (Figure 4D, E). These findings strongly support the conclusion that the enzymatic sulfation activity of Papss is essential for the developmental processes described in this study.
- A main issue that arises from this work is the role of Papss at the cellular level. The results presented convincingly indicate defects in Golgi organization in Papss mutants. Therefore, the defects observed could stem from general defects in the secretion pathway rather than from specific defects on sulfation. This could even underly general/catastrophic cellular defects and lead to cell death (as observed). This observation has different implications. Is this effect observed in SGs also observed in other cells in the embryo? If Papss has a general role in Golgi organization this would be expected, as Papss encodes the only PAPs synthatase in Drosophila. Can the authors test any other mutant that specifically affect Golgi organization and investigate whether this produces a similar phenotype to that of Papss?
Thank you for the comment. To address whether the defects observed in Papss mutants stem from general disruption of the secretory pathway due to Golgi disorganization, we examined mutants of two key Golgi components: Grasp65 and GM130.
In Grasp65 mutants, we observed significant defects in SG lumen morpholgy, including highly irregular SG lumen shape and multiple constrictions (100%; n=10/10). However, the lumen was not uniformly thin as in Papss mutants. In contrast, GM130 mutants-although this line was very sick and difficult to grow-showed relatively normal salivary glands morphology in the few embryos that survived to stage 16 (n=5/5). It is possible that only embryos with mild phenotypes progressed to this stages, limiting interpretation. These data have now been included in Figure 3-figure supplement 2. Overall, while Golgi disruption can affect SG morphology, the specific phenotypes seen in Papss mutants are not fully recapitulated by Grasp65 or GM130 loss.
- A model that conveys the different observations and that proposes a function for Papss in sulfation and Golgi organization (independent or interdependent?) would help to better present the proposed conclusions. In particular, the paper would be more informative if it proposed a mechanism or hypothesis of how sulfation affects SG lumen expansion. Is sulfation regulating a factor that in turn regulates Pio-Dpy matrix? Is it regulating Pio-Dpy directly? Is it regulating a product recognized by WGA? For instance, investigating Alcian blue or sulfotyrosine staining in pio, dpy mutants could help to understand whether Pio, Dpy are targets of sulfation.
Thank you for the comment. We're also very interested in learning whether the regulation of the Pio-Dpy matrix is a direct or indirect consequence of the loss of sulfation on these proteins. One possible scenario is that sulfation directly regulates the Pio-Dpy matrix by regulating protein stability through the formation of disulfide bonds between the conserved Cys residues responsible for ZP module polymerization. Additionally, the Dpy protein contains hundreds of EGF modules that are highly susceptible to O-glycosylation. Sulfation of the glycan groups attached to Dpy may be critical for its ability to form a filamentous structure. Without sulfation, the glycan groups on Dpy may not interact properly with the surrounding materials in the lumen, resulting in an aggregated and condensed structure. These possibilities are discussed in the Discussion.
We have not analyzed sulfation levels in pio or dpy mutants because sulfation levels in mutants of single ZP domain proteins may not provide much information. A substantial number of proteoglycans, glycoproteins, and proteins (with up to 1% of all tyrosine residues in an organism's proteins estimated to be sulfated) are modified by sulfation, so changes in sulfation levels in a single mutant may be subtle. Especially, the existing dpy mutant line is an insertion mutant of a transposable element; therefore, the sulfation sites would still remain in this mutant.
- Interpretation of Papss effects on Pio and Dpy would be desired. The results presented indicate loss of Pio antibody staining but normal presence of cherry-Pio. This is difficult to interpret. How are these results of Pio antibody and cherry-Pio correlating with the results in the trachea described recently (Drees et al. 2023)?
In our original submission, we stated that the uniform luminal mCh-Pio signals were not changed in Papss mutants, but after re-analysis, we found that these signals were actually absent from the expanded luminal region in stage 16 SG (where Dpy-YFP is also absent), and weak mCh-Pio signals colocalize with the condensed Dpy-YFP signals (Figure 5C, D). We have revised the text accordingly.
After cleavages by Np and furin, the Pio protein should have three fragments. The N-terminal region contains the N-terminal half of the ZP domain, and mCh-Pio signals show this fragment. The very C-terminal region should localize to the membrane as it contains the transmembrane domain. We think the middle piece, the C-terminal ZP domain, is recognized by the Pio antibody. The mCh-Pio and Pio antibody signals in the WT trachea (Drees et al., 2023) are similar to those in the SG. mCh-Pio signals are detected in the tracheal lumen as uniform signals, at the apical membrane, and in cytoplasmic puncta. Pio antibody signals are exclusively in the tracheal lumen and show more heterogenous filamentous signals.
In Papss mutants, the middle fragment (the C-terminal ZP domain) seems to be most affected because the Pio antibody signals are absent from the lumen. The loss of Pio antibody signals could be due to protein degradation or epitope masking caused by aECM condensation and protein misfolding. This fragment seems to be key for interacting with Dpy, since Pio antibody signals always colocalize with Dpy-YFP. The N-terminal mCh-Pio fragment does not appear to play a significant role in forming a complex with Dpy in WT (but still aggregated together in Papss mutants), and this can be tested in future studies.
In response to Reviewer 1's comment, we performed an additional experiment to test the role of Np in cleaving Pio to help organize the SG aECM. In this experiment, we overexpressed the WT and mutant form of Np using UAS-Np.WT and UAS-Np.S990A lines (Drees et al., 2019) and analyzed mCh-Pio, Pio antibody, and Dpy-YFP signals. Np.WT overexpression resulted in increased levels of mCh-Pio, Pio, and Dpy-YFP signals in the lumen and at the apical membrane. However, overexpression of Np.S990A resulted in the absence of luminal mCh-Pio signals. Pio antibody signals were strong at the apical membrane but rather weak in the luminal filamentous structures. Since the UAS-Np.S990A line has the GFP tag, we could not reliably analyze Dpy-YFP signals due to overlapping Np.S990A.GFP signals in the same channel. However, the luminal filamentous Pio signals co-localized with GFP signals, and we assume that these overlapping signals could be Dpy-YFP signals.
These results suggest that overexpressed Np.S990A may act in a dominant-negative manner, competing with endogenous Np and impairing proper cleavage of Pio (and mCh-Pio). Nevertheless, some level of cleavage by endogenous Np still appears to occur, as indicated by the residual luminal filamentous Pio signals. These new findings have been incorporated into the revised manuscript and are shown in Figure 6H and 6I.
A proposed model of the Pio-Dpy aECM in WT, Papss, pio, and Np mutants has now been included in Figure 7.
- What does the WGA staining in the lumen reveal? This staining seems to be affected differently in pio and dpy mutants: in pio mutants it disappears from the lumen (as dpy-YFP does), but in dpy mutants it seems to be maintained. How do the authors interpret these findings? How does the WGA matrix relate to sulfated products (using Alcian blue or sulfotyrosine)?
WGA binds to sialic acid and N-acetylglucosamine (GlcNAc) residues on glycoproteins and glycolipids. GlcNAc is a key component of the glycosaminoglycan (GAG) chains that are covalently attached to the core protein of a proteoglycan, which is abundant in the ECM. We think WGA detects GlcNAc residues in the components of the aECM, including Dpy as a core component, based on the following data. 1) WGA and Dpy colocalize in the lumen, both in WT (as thin filamentous structures) and Papss mutant background (as condensed rod-like structures), and 2) are absent in pio mutants. WGA signals are still present in a highly condensed form in dpy mutants. That's probably because the dpy mutant allele (dpyov1) has an insertion of a transposable element (blood element) into intron 11 and this insertion may have caused the Dpy protein to misfold and condense. We added the information about the dpy allele to the Results section and discussed it in the Discussion.
Minor points:
- The morphological phenotypic analysis of Papss mutants (homozygous and transheterozygous) is a bit confusing. The general defects are higher in Papss homozygous than in transheterozygotes over a deficiency. Maybe quantifying the defects in the heterozygote embryos in the Papss mutant collection could help to figure out whether these defects relate to Papss mutation.
We analyzed the morphology of heterozygous Papss mutant embryos. They were all normal. The data and quantifications have now been added to Figure 1-figure supplement 3.
- The conclusion that the apical membrane is affected in Papss mutants is not strongly supported by the results presented with the pattern of Crb (Fig 2). Further evidences should be provided. Maybe the TEM analysis could help to support this conclusion
We quantified Crb levels in the sub-apical and medial regions of the cell and included this new quantification in Figure 2D. TEM images showed variation in the irregularity of the apical membrane, even in WT, and we could not draw a solid conclusion from these images.
- It is difficult to understand why in Papss mutants the levels of WGA increase. Can the authors elaborate on this?
We think that when Dpy (and many other aECM components) are condensed and aggregated into the thin, rod-like structure in Papss mutants, the sugar residues attached to them must also be concentrated and shown as increased WGA signals.
- The explanation about why Pio antibody and mcherry-Pio show different patterns is not clear. If the antibody recognizes the C-t region, shouldn't it be clearly found at the membrane rather than the lumen?
The Pio protein is also cleaved by furin protease (Figure 5B). We think the Pio fragment recognized by the antibody should be a "C-terminal ZP domain", which is a middle piece after furin + Np cleavages.
- The qsm information does not seem to provide any relevant information to the aECM, or sulfation.
Since Qsm has been shown to bind to Dpy and remodel Dpy filaments in the muscle tendon (Chu and Hayashi, 2021), we believe that the different behavior of Qsm in the SG is still informative. As mentioned briefly in the Discussion, the cleaved Qsm fragment may localize differently, like Pio, and future work will need to test this. We have shortened the description of the Qsm localization in the manuscript and moved the details to the figure legend of Figure 5-figure supplement 3.
Reviewer #3 (Significance (Required)):
Previous reports already indicated a role for Papss in sulfation in SG (Zhu et al 2005). Now this work provides a more detailed description of the defects produced by the absence of Papss. In addition, it provides relevant data related to the nature and requirements of the aECM in the SG. Understanding the composition and requirements of aECM during organ formation is an important question. Therefore, this work may be relevant in the fields of cell biology and morphogenesis.
-
Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.
Learn more at Review Commons
Referee #3
Evidence, reproducibility and clarity
In this work Woodward et al focus on the apical extracellular matrix (aECM) in the tubular salivary gland (SG) of Drosophila. They provide new insights into the composition of this aECM, formed by ZP proteins, in particular Pio and Dumpy. They also describe the functional requirements of PAPSS, a critical enzyme involved in sulfation, in regulating the expansion of the lumen of the SG. A detailed cellular analysis of Papss mutants indicate defects in the apical membrane, the aECM and in Golgi organization. They also find that Papss control the proper organization of the Pio-Dpy matrix in the lumen. The work is well presented and the …
Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.
Learn more at Review Commons
Referee #3
Evidence, reproducibility and clarity
In this work Woodward et al focus on the apical extracellular matrix (aECM) in the tubular salivary gland (SG) of Drosophila. They provide new insights into the composition of this aECM, formed by ZP proteins, in particular Pio and Dumpy. They also describe the functional requirements of PAPSS, a critical enzyme involved in sulfation, in regulating the expansion of the lumen of the SG. A detailed cellular analysis of Papss mutants indicate defects in the apical membrane, the aECM and in Golgi organization. They also find that Papss control the proper organization of the Pio-Dpy matrix in the lumen. The work is well presented and the results are consistent.
Main comments:
This work provides a detailed description of the defects produced by the absence of Papss. In addition, it provides many interesting observations at the cellular and tissular level. However, this work lacks a clear connection between these observations and the role of sulfation. Thus, the mechanisms underlying the phenotypes observed are elusive. Efforts directed to strengthen this connection (ideally experimentally) would greatly increase the interest and relevance of this work.
A main issue that arises from this work is the role of Papss at the cellular level. The results presented convincingly indicate defects in Golgi organization in Papss mutants. Therefore, the defects observed could stem from general defects in the secretion pathway rather than from specific defects on sulfation. This could even underly general/catastrophic cellular defects and lead to cell death (as observed). This observation has different implications. Is this effect observed in SGs also observed in other cells in the embryo? If Papss has a general role in Golgi organization this would be expected, as Papss encodes the only PAPs synthatase in Drosophila. Can the authors test any other mutant that specifically affect Golgi organization and investigate whether this produces a similar phenotype to that of Papss?
A model that conveys the different observations and that proposes a function for Papss in sulfation and Golgi organization (independent or interdependent?) would help to better present the proposed conclusions. In particular, the paper would be more informative if it proposed a mechanism or hypothesis of how sulfation affects SG lumen expansion. Is sulfation regulating a factor that in turn regulates Pio-Dpy matrix? Is it regulating Pio-Dpy directly? Is it regulating a product recognized by WGA?
For instance, investigating Alcian blue or sulfotyrosine staining in pio, dpy mutants could help to understand whether Pio, Dpy are targets of sulfation.Interpretation of Papss effects on Pio and Dpy would be desired. The results presented indicate loss of Pio antibody staining but normal presence of cherry-Pio. This is difficult to interpret. How are these results of Pio antibody and cherry-Pio correlating with the results in the trachea described recently (Drees et al. 2023)?
What does the WGA staining in the lumen reveal? This staining seems to be affected differently in pio and dpy mutants: in pio mutants it disappears from the lumen (as dpy-YFP does), but in dpy mutants it seems to be maintained. How do the authors interpret these findings? How does the WGA matrix relate to sulfated products (using Alcian blue or sulfotyrosine)?.
Minor points:
The morphological phenotypic analysis of Papss mutants (homozygous and transheterozygous) is a bit confusing. The general defects are higher in Papss homozygous than in transheterozygotes over a deficiency. Maybe quantifying the defects in the heterozygote embryos in the Papss mutant collection could help to figure out whether these defects relate to Papss mutation.
The conclusion that the apical membrane is affected in Papss mutants is not strongly supported by the results presented with the pattern of Crb (Fig 2). Further evidences should be provided. Maybe the TEM analysis could help to support this conclusion
It is difficult to understand why in Papss mutants the levels of WGA increase. Can the authors elaborate on this?
The explanation about why Pio antibody and mcherry-Pio show different patterns is not clear. If the antibody recognizes the C-t region, shouldn't it be clearly found at the membrane rather than the lumen?
The qsm information does not seem to provide any relevant information to the aECM, or sulfation.
Significance
Previous reports already indicated a role for Papss in sulfation in SG (Zhu et al 2005). Now this work provides a more detailed description of the defects produced by the absence of Papss. In addition, it provides relevant data related to the nature and requirements of the aECM in the SG. Understanding the composition and requirements of aECM during organ formation is an important question. Therefore, this work may be relevant in the fields of cell biology and morphogenesis.
-
Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.
Learn more at Review Commons
Referee #2
Evidence, reproducibility and clarity
Summary:
There is growing appreciation for the important of luminal (apical) ECM in tube development, but such matrices are much less well understood than basal ECMs. Here the authors provide insights into the aECM that shapes the Drosophila salivary gland (SG) tube and the importance of PAPSS-dependent sulfation in its organization and function.
The first part of the paper focuses on careful phenotypic characterization of papss mutants, using multiple markers and TEM. This revealed reduced markers of sulfation (Alcian Blue staining) and defects in both apical and basal ECM organization, Golgi (but not ER) morphology, number and …
Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.
Learn more at Review Commons
Referee #2
Evidence, reproducibility and clarity
Summary:
There is growing appreciation for the important of luminal (apical) ECM in tube development, but such matrices are much less well understood than basal ECMs. Here the authors provide insights into the aECM that shapes the Drosophila salivary gland (SG) tube and the importance of PAPSS-dependent sulfation in its organization and function.
The first part of the paper focuses on careful phenotypic characterization of papss mutants, using multiple markers and TEM. This revealed reduced markers of sulfation (Alcian Blue staining) and defects in both apical and basal ECM organization, Golgi (but not ER) morphology, number and localization of other endosomal compartments, plus increased cell death. The authors focus on the fact that papss mutants have an irregular SG lumen diameter, with both narrowed regions and bulged regions. They address the pleiotropy, showing that preventing the cell death and resultant gaps in the tube did not rescue the SG luminal shape defects and discussing similarities and differences between the papss mutant phenotype and those caused by more general trafficking defects. The analysis uses a papss nonsense mutant from an EMS screen - I appreciate the rigorous approach the authors took to analyze transheterozygotes (as well as homozygotes) plus rescued animals in order to rule out effects of linked mutations.
The 2nd part of the paper focuses on the SG aECM, showing that Dpy and Pio ZP protein fusions localize abnormally in papss mutants and that these ZP mutants (and Np protease mutants) have similar SG lumen shaping defects to the papss mutants. A key conclusion is that SG lumen defects correlate with loss of a Pio+Dpy-dependent filamentous structure in the lumen. These data suggest that ZP protein misregulation could explain this part of the papss phenotype.
Overall, the text is very well written and clear. Figures are clearly labeled. The methods involve rigorous genetic approaches, microscopy, and quantifications/statistics and are documented appropriately. The findings are convincing, with just a few things about the fusions needing clarification.
Minor comments:
Although the Dpy and Qsm fusions are published reagents, it would still be helpful to mention whether the tags are C-terminal as suggested by the nomenclature, and whether Westerns have been performed, since (as discussed for Pio) cleavage could also affect the appearance of these fusions.
The Dpy-YFP reagent is a non-functional fusion and therefore may not be a wholly reliable reporter of Dpy localization. There is no antibody confirmation. As other reagents are not available to my knowledge, this issue can be addressed with text acknowledgement of possible caveats.
TEM was done by standard chemical fixation, which is fine for viewing intracellular organelles, but high pressure freezing probably would do a better job of preserving aECM structure, which looks fairly bad in Fig. 2G WT, without evidence of the filamentous structures seen by light microscopy. Nevertheless, the images are sufficient for showing the extreme disorganization of aECM in papss mutants.
The authors may consider citing some of the work that has been done on sulfation in nematodes, e.g. as reviewed here: https://pubmed.ncbi.nlm.nih.gov/35223994/ Sulfation has been tied to multiple aspects of nematode aECM organization, though not specifically to ZP proteins.
Significance
This study will be of interest to researchers studying developmental morphogenesis in general and specifically tube biology or the aECM. It should be particularly of interest to those studying sulfation or ZP proteins (which are broadly present in aECMs across organisms, including humans).
This study adds to the literature demonstrating the importance of luminal matrix in shaping tubular organs and greatly advances understanding of the luminal matrix in the Drosophila salivary gland, an important model of tubular organ development and one that has key matrix differences (such as no chitin) compared to other highly studied Drosophila tubes like the trachea.
The detailed description of the defects resulting from papss loss suggests that there are multiple different sulfated targets, with a subset specifically relevant to aECM biology. A limitation is that specific sulfated substrates are not identified here (e.g. are these the ZP proteins themselves or other matrix glycoproteins or lipids?); therefore it's not clear how direct or indirect the effects of papss are on ZP proteins. However, this is clearly a direction for future work and does not detract from the excellent beginning made here.
My expertise: I am a developmental geneticist with interests in apical ECM
-
Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.
Learn more at Review Commons
Referee #1
Evidence, reproducibility and clarity
PAPS is required for all sulfotransferase reactions in which a sulfate group is covalently attached to amino acid residues of proteins or to side chains of proteoglycans. This sulfation is crucial for properly organizing the apical extracellular matrix (aECM) and expanding the lumen in the Drosophila salivary gland. Loss of Papss potentially leads to decreased sulfation, disorganizing the aECM, and defects in lumen formation. In addition, Papss loss destabilizes the Golgi structures.
In Papss mutants, several changes occur in the salivary gland lumen of Drosophila. The tube lumen is very thin and shows irregular apical protrusions. …
Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.
Learn more at Review Commons
Referee #1
Evidence, reproducibility and clarity
PAPS is required for all sulfotransferase reactions in which a sulfate group is covalently attached to amino acid residues of proteins or to side chains of proteoglycans. This sulfation is crucial for properly organizing the apical extracellular matrix (aECM) and expanding the lumen in the Drosophila salivary gland. Loss of Papss potentially leads to decreased sulfation, disorganizing the aECM, and defects in lumen formation. In addition, Papss loss destabilizes the Golgi structures.
In Papss mutants, several changes occur in the salivary gland lumen of Drosophila. The tube lumen is very thin and shows irregular apical protrusions. There is a disorganization of the apical membrane and a compaction of the apical extracellular matrix (aECM). The Golgi structures and intracellular transport are disturbed. In addition, the ZP domain proteins Piopio (Pio) and Dumpy (Dpy) lose their normal distribution in the lumen, which leads to condensation and dissociation of the Dpy-positive aECM structure from the apical membrane. This results in a thin and irregularly dilated lumen.
The authors describe various changes in the lumen in mutants, from thin lumen to irregular expansion. I would like to know the correct lumen diameter, and length, besides the total area, by which one can recognize thin and irregular.
The rescue is about 30%, which is not as good as expected. Maybe the wrong isoform was taken. Is it possible to find out which isoform is expressed in the salivary glands, e.g., by RNA in situ Hyb? This could then be used to analyze a more focused rescue beyond the paper.
Crb is a transmembrane protein on the apicolateral side of the membrane. Accordingly, the apicolateral distribution can be seen in the control and the mutant. I believe there are no apparent differences here, not even in the amount of expression. However, the view of the cells (frame) shows possible differences. To be sure, a more in-depth analysis of the images is required. Confocal Z-stack images, with 3D visualization and orthogonal projections to analyze the membranes showing Crb staining together with a suitable membrane marker (e.g. SAS or Uif). This is the only way to show whether Crb is incorrectly distributed. Statistics of several papas mutants would also be desirable and not just a single representative image. When do the observed changes in Crb distribution occur in the development of the tubes, only during stage 16? Is papass only involved in the maintenance of the apical membrane? This is particularly important when considering the SJ and AJ, because the latter show no change in the mutants.
A change in the ECM is only inferred based on the WGA localization. This is too few to make a clear statement. WGA is only an indirect marker of the cell surface and glycosylated proteins, but it does not indicate whether the ECM is altered in its composition and expression. Other important factors are missing here. In addition, only a single observation is shown, and statistics are missing.
Reduced WGA staining is seen in papas mutants, but this could be due to other circumstances. To be sure, a statistic with the number of dots must be shown, as well as an intensity blot on several independent samples. The images are from single confocal sections. It could be that the dots appear in a different Z-plane. Therefore, a 3D visualization of the voxels must be shown to identify and, at best, quantify the dots in the organ.
A colocalization analysis (statistics) should be shown for the overlap of WGA with ManII-GFP.
I do not understand how the authors describe "statistics of secretory vesicles" as an axis in Figure 3p. The TEM images do not show labeled secretory vesicles but empty structures that could be vesicles.
The quality of the presented TEM images is too low to judge any difference between control and mutants. Therefore, the supplement must present them in better detail (higher pixel number?).
Line 266: the conclusion that apical trafficking is "significantly impaired" does not hold. This implies that Papass is essential for apical trafficking, but the analyzed ECM proteins (Pio, Dumpy) are found apically enriched in the mutants, and Dumpy is even secreted. Moreover, they analyze only one marker, Sec15, and don't provide data about the quantification of the secretion of proteins.
DCP-1 was used to detect apoptosis in the glands to analyze acellular regions. However, the authors compare ST16 control with ST15 mutant salivary glands, which is problematic. Further, it is not commented on how many embryos were analyzed and how often they detect the dying cells in control and mutant embryos. This part must be improved.
WGA and Dumpy show similar condensed patterns within the tube lumen. The authors show that dumpy is enriched from stage 14 onwards. How is it with WGA? Does it show the same pattern from stage 14 to 16? Papass mutants can suffer from a developmental delay in organizing the ECM or lack of internalization of luminal proteins during/after tube expansion, which is the case in the trachea.
Line 366. Luminal morphology is characterized by bulging and constrictions. In the trachea, bulges indicate the deformation of the apical membrane and the detachment from the aECM. I can see constrictions and the collapsed tube lumen in Fig. 6C, but I don't find the bulges of the apical membrane in pio and Np mutants. Maybe showing it more clearly and with better quality will be helpful.
- The authors state that Papass controls luminal secretion of Pio and Dumpy, as they observe reduced luminal staining of both in papass mutants. However, the mCh-Pio and Dumpy-YFP are secreted towards the lumen. Does papass overexpression change Pio and Dumpy secretion towards the lumen, and could this be another explanation for the multiple phenotypes? Regulation of luminal ZP protein level is essential to modulate the tube expansion; therefore, Np releases Pio and Dumpy in a controlled manner during st15/16. Thus, the analysis of Pio and Dumpy in NP overexpression embryos will be critical to this manuscript to understand more about the control of luminal ZP matrix proteins.
- Minor: Fig. 5 C': mChe-Pio and Dumpy-YFP are mixed up at the top of the images. Sup. Fig7. A shows Pio in purple but B in green. Please indicate it correctly.
Significance
In 2023, the functions of Pio, Dumpy, and Np in the tracheal tubes of Drosophila were published. The study here shows similar results, with the difference that the salivary glands do not possess chitin, but the two ZP proteins Pio and Dumpy take over its function. It is, therefore, a significant and exciting extension of the known function of the three proteins to another tube system. In addition, the authors identify papass as a new protein and show its essential function in forming the luminal matrix in the salivary glands. Considering the high degree of conservation of these proteins in other species, the results presented are crucial for future analyses and will have further implications for tubular development, including humans.
-